Small-Mid Cap Growth Equity

Investment Philosophy and Process:

  • Invest in companies with recurring revenue business models, defined as having products and services with <2 year life span
  • Utilize a fundamental, bottom-up approach to identify high quality growing companies with good growth prospects, strong cash flow and good balance sheets
  • Purchase securities at attractive valuations as determined by AMI’s proprietary models
  • Concentrated portfolio of 30-35 names with turnover of approximately 35-45%
  • Target in-line participation in up markets, with significant downside protection
  • Total Strategy Assets: $61 Million*

*As of  June 30, 2017


Click on the images below to see larger versions.








1.       INC Research




2.       Ligand Pharmaceuticals




3.       Avery Dennison




4.       Blackhawk Network




5.       Merit Medical Systems




6.       Aramark




7.       Broadridge Financial




8.       Envision Healthcare




9.       Anika Therapeutics




10.    Broadsoft




As of 6-30-17. Holdings are subject to change.  The securities identified and described above do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable.  A complete list of all buy and sell recommendations for this strategy within the last 12 months is available upon request.  AMI Asset and/or one or more of its employee may have a position in these securities and may purchase and sell such securities from time to time.



  AMI SMID Cap Growth Russell 2500 Growth
P/E 21.2x 33.5x
Price to book value 3.6x 5.2x
EPS LTG Estimate 14.7% 10.1%
Dividend Yield 0.5% 0.8%
Dollar Weighted Market Cap. (Bil) $4.1 $4.8
Median Market Cap. (Bil) $3.1 $1.3
Positions 34 1,436

As of 6-30-17.  Source – AMI, Russell. The above information is based on a representative account and clients accounts may vary.  The portfolio characteristics information is being presented as supplemental information to the AMI Domestic Small-Mid Cap Growth Composite.  *AMI internal estimate.




AMI 2nd Quarter 2017 Small-Mid Cap Growth Factsheet